APA (7th ed.) Citation

R, S., Y, L., H, Z., Y, L., H, H., D, H., & D, L. (2026). Bioinformatics-driven insights: Rapamycin-mediated CaMK2D inhibition alleviates intestinal ischemia-reperfusion injury. Frontiers in immunology, 16, 1684853. https://doi.org/10.3389/fimmu.2025.1684853

Chicago Style (17th ed.) Citation

R, Sheng, Liang Y, Zhang H, Lai Y, Hong H, Huang D, and Liu D. "Bioinformatics-driven Insights: Rapamycin-mediated CaMK2D Inhibition Alleviates Intestinal Ischemia-reperfusion Injury." Frontiers in Immunology 16 (2026): 1684853. https://doi.org/10.3389/fimmu.2025.1684853.

MLA (9th ed.) Citation

R, Sheng, et al. "Bioinformatics-driven Insights: Rapamycin-mediated CaMK2D Inhibition Alleviates Intestinal Ischemia-reperfusion Injury." Frontiers in Immunology, vol. 16, 2026, p. 1684853, https://doi.org/10.3389/fimmu.2025.1684853.